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Background
Renal cell carcinoma (RCC) is a relatively rare tumor, account-
ing for just over 2% of all adult malignancies as of 2008.1
Metastatic disease occurs through hematogenous spread that
most often manifests in bone, lung, and the liver; however,
the head and neck have been reported sites of metastasis in
up to 15% of patients.2 Metastatic disease tends to present at
or near the time of initial diagnosis, but there have been
reported cases of metastases to the head and neck manifest-
ing greater than 10 years following primary nephrectomy.2,3
The most common site of metastatic disease in the head and
neck is the thyroid gland, but the sinonasal cavity is also a
frequent site, and metastases to the neck, tongue,4 facial skin,
and other sites have also been reported.2,5,6 Epistaxis, facial
pain, or nasal obstruction maybethe presentingsymptom for
patientswithmetastatic RCC.7,8Tumor in thesinonasal cavity
can result in a signiﬁcant decrease in quality of life due to
recurrent severe epistaxis, nasal obstruction, and local pain.9
Any patient presenting with nasal obstruction or epistaxis
and a history of RCC should have metastatic disease included
in the differential diagnosis.
Keywords
► r e n a lc e l lc a r c i n o m a
► quality of life
► embolization
► epistaxis
► nasal obstruction
Abstract Objectives To describe the presentation, work-up, and management of patients with
metastatic renal cell carcinoma (RCC) to the sinonasal cavity and skull base, and to
describe our current treatment algorithm of endoscopic surgical resection followed by
radiation therapy.
Design Retrospective review of two recent cases from our institution over a 1-year
period, with a relevant review of the literature.
Setting A large regional tertiary care facility.
Participants Consecutive cases of RCC with metastases to the sinonasal cavity
presenting to our institution.
Main Outcome Measures Preoperative and postoperative sinonasal outcome test
(SNOT)-22 scores, duration of hospital stay, complications, and local disease control
Results Patients in this series underwent preoperative embolization followed by
endoscopic resection without complication. Postoperatively they were treated with
radiation therapy. They experienced improvement in their SNOT-22 scores and are
currently free of local disease.
Conclusion Metastatic RCC to the sinonasal cavity can be safely treated with
preoperative embolization followed by endoscopic surgical resection and radiation
therapy, which can result in improvement in sinonasal quality of life and is a potential
adjunct for local control of disease.
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.The typical work-up for a patient with a presumed sino-
nasal mass should include nasal endoscopy, followed by
prebiopsy imaging with contrast-enhanced computed to-
mography (CT) and magnetic resonance imaging (MRI) if
the lesion extends to the skull base. Several reports have
described profuse bleeding at the time of biopsy of sinonasal
RCC due to the hypervascular nature of these tumors, requir-
ing external carotid ligation;10 thus, any biopsy of a suspi-
cious lesion should be performed in the operating room.
Historically, external beam radiation therapy has been the
treatment of choice for metastatic sinonasal RCC, with or
without concurrent chemotherapy.10 Surgical resection has
been controversial and usually reserved for small solitary
lesions or for debulking after primary radiotherapy.
We present two cases of metastatic RCC to the sinonasal
cavity and skull base that were successfully resected endo-
scopically after preoperative embolization. Both patients had
signiﬁcant sinonasal symptoms that resolved posttreatment.
We discuss each patient’s presentation, detail our institu-
tion’s work-up and treatment algorithm, and highlight the
safety and minimal impact of surgery followed by postopera-
tive radiation.
Case 1
A 53-year-old white man had a 4-month history of left-sided
nasal obstruction and facial pressure. He noted discolored,
brown nasal drainage, but did not have frank epistaxis. At the
time of initial evaluation his sinonasal outcome test (SNOT-
22) score was 32 (where 7 or less is “normal”11 and higher
values indicate more severe sinonasal symptoms). His past
medical history was signiﬁcant for a right nephrectomy for a
T1N0 renal cell carcinoma 10 years prior to presentation. On
exam, nasal endoscopy was remarkable for a mass in the left
nasal cavity, medial to the middle turbinate. A CT scan
revealed a vascular, expansile, polypoid soft tissue mass,
measuring 4  3  2c ma n dﬁlling the space medial to the
middle turbinate and the sphenoethmoid recess, extending
into the sphenoid sinus and nasopharynx. Superiorly, it
extended to the cribriform plate but did not appear to breach
the skull base, and bony remodeling along the medial maxil-
lary wall was noted. There was no radiologic evidence of
intracranial extension (►Fig. 1).
An initial biopsy resulted in extensive bleeding, and pa-
thology was suggestive of a benign process, such as heman-
gioma.Subsequentlyhewasreferredtoourserviceforfurther
treatment. Given the degree of bleeding at the time of initial
biopsy, preoperative embolization was performed. The angi-
ographyatthetime ofembolization showed that themajority
of the blood supply was from the internal carotid system via
the anterior ethmoid arteries, which could not be embolized
Fig. 1 (A) Noncontrast coronal computed tomography scan demonstrating soft tissue mass extending to the cribriform plate and skull base.
(B) 18-month postoperative T1 postcontrast magnetic resonance imaging demonstrating patent left maxillary antrostomy and no evidence of
recurrent disease.
Fig. 2 Sagittal angiogram of the left internal carotid demonstrating
signiﬁcant anterior ethmoid artery contribution to the lesion.
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.(►Fig. 2). Contributions from the sphenopalatine artery were
embolized (►Fig. 3).
The day following embolization, the mass was removed
endoscopically en bloc with minimal intraoperative bleeding
after selective endoscopic bipolar cautery of several feeding
vessels from the anterior ethmoid artery. The patient tolerat-
ed the procedure well and was discharged the day following
surgerywithoutcomplication.Finalpathologywasconsistent
with RCC and demonstrated typical clear cells arranged in
nests that stained positively for RCC antigen (►Fig. 4).
The patient received postoperative radiation therapy.
Twelve months after completion of treatment, he was found
to have a new thyroid mass that was suspicious for papillary
thyroid carcinoma on ﬁne-needle aspiration. He underwent
total thyroidectomy, which conﬁrmed papillary thyroid car-
cinomabut wasalsoincidentallynotedtocontainsmallfociof
RCC. In follow-up, he has no evidence of sinonasal or thyroid
recurrenceafter18months(►Fig.1).HisSNOT-22scoreathis
most recent visit was persistently improved to 7, within the
normal range (►Table 1).
Case 2
A 67-year-old white man presented with several weeks of
worsening intermittent epistaxis and nasal obstruction. His
SNOT-22 score at thetime of initial evaluationwas 23. Hehad
a history of T3bN2 RCC and underwent radical nephrectomy
with retroperitoneal lymph node dissection 3 years prior to
presentation. He developed several subcentimeter pulmo-
nary nodules but had not received adjuvant systemic therapy
given their slow growth rate. Nasal endoscopy revealed a
large submucosal mass ﬁlling the medial meatus on the right
and signiﬁcant submucosal bulging of the posterior septum
Fig. 3 (A) Sagittal angiogram of the left external carotid showing sphenopalatine contribution. (B) Postembolization of the left sphenopalatine
artery.
Fig. 4 (A) A 1000 hematoxylin and eosin stain showing typical clear cells arranged in nests with pooling of red blood cells. (B) Renal cell
carcinoma antigen conﬁrms the diagnosis with apical cytoplasmic staining.
Table 1 Comparison of pre and postoperative Sinonasal
Outcome Test scores
Case Preoperative
SNOT-22 Score
Postoperative
SNOT-22 Score
Case 1 32 7
Case 2 23 5
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.on both sides. An outside biopsy conﬁrmed the diagnosis of
metastatic RCC.
MRI revealed a bulky 4  3  4 cm mass within the right
anterior ethmoid cavity, bilateral posterior ethmoid air cells,
andnasal cavitywithdestructionof theposterior septum,the
anterior intersphenoid septum, and clivus, as well as exten-
sion of the mass into the sphenoid sinus on both sides.
(►Fig. 5) There was no radiologic evidence of intracranial
extension. Preoperative embolization of the mass was per-
formed and the majority of the blood supply was from the
distal branches of the internal maxillary artery bilaterally
(►Fig. 6). Endoscopic resection was performed the following
day. Gross tumor resection was accomplished, but the tumor
extended into the clivus and was likely to have microscopic
disease present in the marrow space beyond the area of clival
resection. The patient tolerated the procedure well without
complication and was discharged the following day. He has
just completed adjuvant radiation therapy. At 3-month fol-
low-up, his SNOT-22 score had decreased to 5.
Discussion
RCC remains a relatively rare tumor, accounting for just over
2%ofallmalignantdisease.1IntheUnitedStates,anestimated
58,000 men and women are newly diagnosed each year, at a
ratioof1.5to1,respectively.12MetastaticdiseaseinRCCmost
frequently presents in the lungs (74%), bone (42%), or liver
(41%).13 Fifteen percent of patients with RCC experience
metastatic disease to the head and neck at or after the time
of initial diagnosis.2 The most common location above the
clavicle is the thyroid bed, with the nose and paranasal
sinuses the second most frequent site.6 Because the classic
triadofﬂankpain,hematuria,andapalpableabdominalmass
occursinonly10%ofRCCpatients,14cliniciansseeingpatients
Fig. 5 (A) Axial T1 postcontrast image showing an enhancing lobulated mass centered in the posterior ethmoid air cells, extending into the
sphenoid and to the clivus. (B) Axial computed tomography without contrast showing bony erosion of the right clivus.
Fig.6 (A)Rightexternalcarotidangiogramshowingdensevascularcontributionfromtheinternalmaxillaryartery.(B)Followingembolizationof
the internal maxillary artery.
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.with symptoms of metastatic disease must maintain a high
indexof suspicion, even in the absence of a historyof primary
RCC. Overall 5-year survival rates in the United States have
increased from 63.7% in 1988 to 73.9% in 2002; however, this
maybeduetoaleadtimebiasduetoearlierdetectionofsmall
localized tumors incidentally noted on abdominal imaging
studies.12 When reviewing patients with metastatic disease,
their 5-year survival remained relatively dismal at 11.9%.
Metastatic disease in RCC is thought to occur via hematog-
enous spread, with two possible mechanisms to the head and
neck region. One is via inferior vena cava spread to the lungs,
wheresmalldepositsmayresidebut maynot yetbevisibleon
chest radiograph. These cells may then travel to the head and
neck via the carotid arterial system. This theory suggests that
patients with metastatic disease in thehead and neck already
have widely disseminated RCC. A second possibility outlined
byNahumandBailyin1963isretrogrademovementoftumor
cells up the Batson sacral venous plexus to thehead and neck,
bypassing the lungs and resulting in seeding of the paranasal
sinuses and thyroid as isolated metastatic sites.15 Unfortu-
nately, the clinical behavior of RCC is frequently noted to be
unpredictableinitslocationandtimingofmetastasis.10Inour
series, one patient with a T1 tumor developed an isolated
paranasal sinus metastasis followed by micrometastasis in
thethyroid bed morethan 10 years after initial diagnosis.Our
second patient developed pulmonary metastases followed by
a sinonasal metastasis 3 years after initial diagnosis.
Because patients may present at a signiﬁcant delay from
their primary treatment, diagnosis can be a challenge. Nasal
obstruction and facial pain are common in many sinonasal
tumors, but recurrent profuse epistaxis appears to be speciﬁc
tohemangiomas and certain malignancies, includingRCCand
melanoma.8 In a series of six patients with metastatic RCC to
the nose and paranasal sinuses, two patients who underwent
biopsy had profuse bleeding that necessitated external carot-
id artery ligation.10 Spontaneous epistaxis from these lesions
can result in anemia and require recurrent transfusions,8 and
authors in one report argue that even in the setting of
multiple sinonasal metastases, endoscopic resection should
beperformedwiththeprimarypurposeof limitingrecurrent,
massive epistaxis and improving quality of life.16
In general, work-up for a sinonasal mass should include
endoscopic examination, followed by a CTscan with contrast,
prior to considering biopsy. This is the imaging test of choice
for its ability to delineate vascularity and skull base involve-
ment. Typically, metastatic RCC lacks tumor calciﬁcation and
is brightly enhancing on CT with contrast, similar to the CT
appearance of primary renal disease.17
With superior visualization and ability to control intra-
operative epistaxis, endoscopic biopsy has now become the
standard of care for diagnosis of a sinonasal mass.18 Patho-
logic specimens typically demonstrate clear cytoplasm and
show cells arranged in nests and cords with prominent
vascular lakes (►Fig. 4). The histologic diagnosis may be
supported by RCC antigen immunostain.
In the largest case series in the literature of patients with
RCC metastatic to the nose and paranasal sinuses, Simo et al
discuss six patients,10 all treated with radiotherapy following
biopsy. Theyargue that although RCC has been thoughtof as a
radioresistant tumor, this isprimarily because of the inability
to obtain high doses of radiation in the retroperitoneum, and
that the anatomy of the nose and paranasal sinuses would
allow for an effective dose of radiation to treat the disease.
Thirty percent of their patients did have a complete response,
whereas 50% had a partial response and one had no response
(stable disease). Patients did require periodic nasal decrust-
ingfollowingexternalbeamradiation,but theauthorsdidnot
elaborate on the effect of treatment on quality of life. At
26 months, four of their patients had died and two remained
alive. The majority of the patients who died had advanced
metastatic disease in the lung or bone as well.
Two previous reports describe the successful endoscopic
resection of localized disease in the paranasal sinuses, noting
survival ratesgreater than5 yearsafter surgery.2,8 In the past,
radiation therapy alone has been the treatment of choice for
metastatic disease. Our case series has demonstrated that for
isolated lesions that impact on patient quality of life, endo-
scopic resection can be effective and safe, carrying minimal
morbidity and greatly improving sinonasal complaints. Al-
though epidemiologic data suggest that 5-year survival for
patients with metastatic disease is low,12 there is a real
opportunity to improve patient symptoms through manage-
ment of sinonasal metastases. Local control of head and neck
metastases may allow patients improved quality of life while
receiving systemic adjuvant therapy for more widely dissem-
inated disease. Adjuvant treatment now includes anti–vascu-
lar endothelial growth factor (VEGF) and mTOR pathway
inhibitors, which have been shown to improve progression-
free survival in advanced RCC.19 These agents are now being
added to our treatment plans where appropriate.
At our institution, preoperative embolization and endo-
scopic resection followed by proton beam radiation is the
treatment algorithm for resectable disease. Embolization
provides a superior operative ﬁeld and visualization while
limiting blood loss, and has been shown to be extremely safe
in the head and neck.20 Even when feeding vessels arise from
the internal carotid system, the preoperative angiogram and
external system embolization can greatly help with surgical
planning. Our limited series of patients had minimal blood
loss and no signiﬁcant morbidity, and they were discharged
the day following surgery. Their sinonasal symptoms mirror
that of a healthy population on the SNOT-22,11 and in our
short period of follow-up, therehas been no evidence of local
disease recurrence.
Conclusion
RCC is a relatively rare tumor with unpredictable metastatic
potential. Sinonasal metastases may be the initial presenta-
tion of this disease. Deﬁnitive diagnosis depends on histopa-
thology, and endoscopic biopsy can be used for this purpose.
If metastatic RCC is suspected, preoperative preparation for
blood loss is essential given the signiﬁcant vascularity of this
tumor. Metastatic sinonasal RCC has been traditionally
treated with radiation therapy. Our case series demonstrates
that patients with metastatic RCC to the sinonasal cavity can
Journal of Neurological Surgery Reports Vol. 74 No. R2/2013
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.be safely and successfully treated with preoperative emboli-
zation followed by endoscopic resection. Our patients had no
signiﬁcant blood loss and were discharged the day following
surgery.Theyalso had asigniﬁcant improvement insinonasal
symptoms and quality of life. The treatment algorithm at our
institution currently involves endoscopic surgical resection
for lesions that can be removed with minimal morbidity,
followed by radiation therapy.
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